News Releases

News Release

Meridian Bioscience to Present at the Sidoti & Company, LLC Sixth Annual West Coast Emerging Growth International Investor Forum

September 19, 2007 at 10:01 AM EDT

CINCINNATI--(BUSINESS WIRE)--Sept. 19, 2007--Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO) today announced that the Company has been invited to present at the Sidoti & Company, LLC Sixth Annual West Coast Emerging Growth International Investor Forum at the Ritz-Carlton Hotel in San Francisco. Bill Motto, Chairman and CEO and Jack Kraeutler, President and COO, are scheduled to present on Monday, September, 24, 2007 at 9:40 a.m. PDT. A question and answer session will follow and some of the information provided during the session may not have been previously disclosed. Mr. Motto and Mr. Kraeutler will be available to meet with investors during the Conference.

On September 24, 2007, the information presented at the Conference can be viewed on the Company's website,, under Events and Presentations on the Investors Relations page.

Meridian is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Utilizing a variety of methods, these products and diagnostic tests provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as gastrointestinal, viral and respiratory infections. Meridian's diagnostic products are used outside of the human body and require little or no special equipment. The Company's products are designed to enhance patient well-being while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal and upper respiratory infections, serology, parasitology and fungal disease diagnosis. In addition, Meridian is a supplier of rare reagents, specialty biologicals and related technologies used by biopharmaceutical companies engaged in research for new drugs and vaccines. The Company markets its products and technologies to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers and biotech companies in more than 60 countries around the world. The Company's shares are traded through NASDAQ's Global Select Market, symbol VIVO. Meridian's website address is

CONTACT: Meridian Bioscience, Inc.
John A. Kraeutler, President, 513-271-3700

SOURCE: Meridian Bioscience, Inc.